Biomea Fusion to Become a Diabetes & Obesity Medicines Company
Go back to Biomea Fusion to Become a Diabetes & Obesity Medicines Company| (NASDAQ: BMEA) | Delayed: 1.32 -0.17 (11.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.49 | 52 Week High | $ | |||
| Open | $1.49 | 52 Week Low | $ | |||
| Day High | $1.49 | P/E | N/A | |||
| Day Low | $1.30 | EPS | $ | |||
| Volume | 3,080,856 | |||||
